BioMarin Pharmaceutical Inc. (BMRN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 12:55PM EDT. Market open.
| Previous Close | 90.07 |
| Open | 89.67 |
| Bid | 88.80 x 100 |
| Ask | 93.28 x 100 |
| Day's Range | 88.78 - 90.18 |
| 52 Week Range | 76.02 - 99.56 |
| Volume | |
| Avg. Volume | 1,403,309 |
| Market Cap | 16.876B |
| Beta (5Y Monthly) | 0.32 |
| PE Ratio (TTM) | 102.21 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
BioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?
BioMarin (BMRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GuruFocus.com
Insider Sell: Biomarin Pharmaceutical Inc (BMRN) Chief Accounting Officer Erin Burkhart ...
Biomarin Pharmaceutical Inc (NASDAQ:BMRN), a global biotechnology company focused on developing and commercializing innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases, has reported an insider sell according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.